Reply to the Editor  by Olsen, Margaret A. et al.
Reply to the Editor:
We appreciate the interest shown by Dr
Allen in our work concerning leg harvest
surgical site infection rates after coronary
artery bypass graft surgery and the oppor-
tunity to respond to his comments. We
agree that many wound complications oc-
cur after discharge and, as stated in our
article, share his concern that some may be
missed if outpatient follow-up is incom-
plete. We should note, however, that the
Society of Thoracic Surgeons (STS) data-
base calls for 30-day follow-up, not just
in-hospital follow-up. Indeed, as stated in
the Methods section, at Washington Uni-
versity our data coordinators contact all
treating physicians and cardiothoracic sur-
geons by phone at 30 days after the oper-
ation for follow-up information. Because
the National Nosocomial Infection Surveil-
lance System/Centers for Disease Control
(NNIS/CDC) definition of surgical site in-
fection requires that signs and symptoms of
infection begin within 30 days of surgery,1
by definition late-onset infections were not
included in our study.
Dr Allen also reminds us of significant
contributions from other authors. We did
indeed cite other publications by these
same authors, and we appreciate the addi-
tion of the reference by Allen and col-
leagues2 to the debate. The publications
cited in Allen’s letter, however, describe
risk factors associated with wound compli-
cations in general2,3 or impaired wound
healing4 after saphenous vein harvest in
patients undergoing coronary artery bypass
grafting. In the publication of Allen and
colleagues3 wound complications included
hematoma, dehiscence, cellulitis, necrosis,
or abscess requiring dressing changes, an-
tibiotics, or de´bridement. In the publication
of Utley and associates,4 impaired wound
healing included inflammation, separation,
cellulitis, lymphangitis, drainage, necrosis,
or abscess requiring dressings, antibiotics,
or de´bridement. In light of the variety of
different complications included in these
two studies, it is not surprising that their
published rates of wound complications
would be much higher than the 4.5% sur-
gical site infection rate we reported. Our
publication pertains specifically to risk fac-
tors for leg surgical site infections, not all
“wound complications.” We applied strict
criteria, which we consider a strength of the
study, and used prospective data available
in our institutional STS database and our
hospital infection control database to deter-
mine the rate of surgical site infection in
this patient population. As stated in the
Methods section, all medical records were
reviewed for patients with apparent surgi-
cal site infection, and the diagnosis of in-
fection was confirmed with standardized
criteria established by the NNIS/CDC1 to
define deep and superficial leg harvest sur-
gical site infection. We reported a 4.5%
rate of confirmed leg infections according
to the NNIS/CDC definitions for infection.
We appreciate Dr Allen’s enthusiasm
for endoscopic vein harvest. We did not
cite the prospective study of endoscopic
versus traditional saphenous vein harvest
by Allen and colleagues2 because they an-
alyzed total wound complication rates
rather than surgical site infection rates. In
fact if we use the numbers reported in this
publication to look specifically at infection,
the difference between the two groups did
not achieve statistical significance. Al-
though there were fewer patients with in-
fection after endoscopic harvest of the sa-
phenous vein (1/51 with cellulitis after
endoscopic harvest vs 6/58 with cellulitis,
cellulitis/abscess, or cellulitis/dehiscence
after traditional harvest, P .118 by Fisher
exact test), this study was underpowered to
analyze differences in surgical site infec-
tion rates. Even with a 10% surgical site
infection rate in the traditional harvest
group and a 5-fold decrease in infection
rates, the power to detect a significant dif-
ference in infection rates with the number
of patients enrolled was only 40%.
It is important to compare apples with
apples. We used very strict definitions of
surgical site infection and specific fol-
low-up times to establish the rate of leg
harvest site surgical site infection at our
institution. As stated in the conclusions of
our study, however, we recognize that the
4.5% surgical site infection rate identified
was almost certainly an underestimate of
the “true” surgical site infection rate. Every
effort was made by our STS data coordi-
nator to obtain complete 30-day follow-up
for all patients, but in an imperfect world
we recognize that follow-up was not 100%
accurate. Databases such as that run by the
STS do not track events, data coordinators
do. They must be provided with specific
and usable definitions with which to do
their work, and recognition of a job well
done. We have confidence in our data and
in our analysis.
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